Maravai LifeSciences Holdings, Inc. (MRVI)
USD 1.91
(-1.8%)
USD 1.91
(-1.8%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 712.4 Million USD | -92.16% |
| 2022 | 609.98 Million USD | 4.55% |
| 2021 | 585.77 Million USD | 481.88% |
| 2020 | 138.27 Million USD | 92.6% |
| 2019 | 48.19 Million USD | 21.86% |
| 2018 | 33.24 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -3.5 Million USD | -99.68% |
| 2024 Q2 | 2.73 Million USD | 332.93% |
| 2023 Q4 | 13.19 Million USD | 338.4% |
| 2023 FY | - USD | -92.16% |
| 2023 Q1 | 8.74 Million USD | -92.23% |
| 2023 Q3 | -5.53 Million USD | 36.82% |
| 2023 Q2 | -8.75 Million USD | -200.15% |
| 2022 Q4 | 112.49 Million USD | -3.76% |
| 2022 Q3 | 116.89 Million USD | -31.89% |
| 2022 Q2 | 171.62 Million USD | -1.79% |
| 2022 Q1 | 174.75 Million USD | 12.93% |
| 2022 FY | - USD | 4.55% |
| 2021 Q4 | 154.74 Million USD | 6.2% |
| 2021 FY | - USD | 481.88% |
| 2021 Q3 | 145.7 Million USD | -5.54% |
| 2021 Q2 | 154.24 Million USD | 66.85% |
| 2021 Q1 | 92.44 Million USD | 290.94% |
| 2020 Q1 | 22.66 Million USD | 182.37% |
| 2020 Q3 | 52.42 Million USD | 258.7% |
| 2020 Q2 | 14.61 Million USD | -35.5% |
| 2020 FY | - USD | 92.6% |
| 2020 Q4 | 23.64 Million USD | -54.89% |
| 2019 Q4 | 8.02 Million USD | 0.0% |
| 2019 FY | - USD | 21.86% |
| 2018 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| AbCellera Biologics Inc. | -192.15 Million USD | 470.741% |
| Alkermes plc | 495.04 Million USD | -43.907% |
| Agenus Inc. | -145.92 Million USD | 588.206% |
| Aptorum Group Limited | -9.59 Million USD | 7521.702% |
| Ardelyx, Inc. | -55.35 Million USD | 1387.005% |
| Dyadic International, Inc. | -8.22 Million USD | 8756.52% |
| Eton Pharmaceuticals, Inc. | -291 Thousand USD | 244914.089% |
| Lantern Pharma Inc. | -15.78 Million USD | 4612.72% |
| Inhibikase Therapeutics, Inc. | -19.91 Million USD | 3677.716% |
| Novavax, Inc. | -487.39 Million USD | 246.168% |
| Janux Therapeutics, Inc. | -71.02 Million USD | 1103.054% |
| Pyxis Oncology, Inc. | -78.49 Million USD | 1007.608% |
| TransCode Therapeutics, Inc. | -17.97 Million USD | 4063.674% |
| Ocuphire Pharma, Inc. | -9.96 Million USD | 7246.96% |
| Outlook Therapeutics, Inc. | -57.37 Million USD | 1341.651% |
| Madrigal Pharmaceuticals, Inc. | -379.96 Million USD | 287.491% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | 3054.595% |
| SELLAS Life Sciences Group, Inc. | 529 Thousand USD | -134570.888% |
| Syros Pharmaceuticals, Inc. | -157.19 Million USD | 553.201% |
| Barinthus Biotherapeutics plc | -74.81 Million USD | 1052.229% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | 3633.95% |
| Xeris Biopharma Holdings, Inc. | -23.73 Million USD | 3101.513% |
| Clearside Biomedical, Inc. | -23.05 Million USD | 3189.639% |
| C4 Therapeutics, Inc. | -122.1 Million USD | 683.449% |
| Alnylam Pharmaceuticals, Inc. | -258.24 Million USD | 375.869% |
| AlloVir, Inc. | -190.14 Million USD | 474.664% |
| Arrowhead Pharmaceuticals, Inc. | -175.67 Million USD | 505.534% |
| VYNE Therapeutics Inc. | -29.25 Million USD | 2534.92% |
| Bicycle Therapeutics plc | -183.4 Million USD | 488.445% |
| BioXcel Therapeutics, Inc. | -165.42 Million USD | 530.664% |
| ChromaDex Corporation | -3.89 Million USD | 18395.044% |
| Chimerix, Inc. | -92.97 Million USD | 866.245% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.43 Million USD | 1703.2% |
| Caribou Biosciences, Inc. | -112.53 Million USD | 733.061% |
| CRISPR Therapeutics AG | -202.7 Million USD | 451.458% |
| Precision BioSciences, Inc. | -32.04 Million USD | 2323.36% |
| Fate Therapeutics, Inc. | -172.22 Million USD | 513.641% |
| Fortress Biotech, Inc. | -133.64 Million USD | 633.069% |
| Fortress Biotech, Inc. | -133.64 Million USD | 633.069% |
| HOOKIPA Pharma Inc. | -77.34 Million USD | 1021.103% |
| ImmuCell Corporation | -2.5 Million USD | 28549.964% |
| IDEAYA Biosciences, Inc. | -130.42 Million USD | 646.238% |
| Immix Biopharma, Inc. | -16.13 Million USD | 4515.126% |
| Incyte Corporation | 919.42 Million USD | 22.516% |
| Innoviva, Inc. | 248.96 Million USD | -186.154% |
| IO Biotech, Inc. | -91.22 Million USD | 880.91% |
| Jaguar Health, Inc. | -33.13 Million USD | 2250.279% |
| Keros Therapeutics, Inc. | -152.17 Million USD | 568.145% |
| Ligand Pharmaceuticals Incorporated | 101.72 Million USD | -600.315% |
| ContextLogic Inc. | -324 Million USD | 319.879% |
| MiMedx Group, Inc. | 40.51 Million USD | -1658.297% |
| MEI Pharma, Inc. | 26.38 Million USD | -2600.565% |
| NextCure, Inc. | -59.03 Million USD | 1306.675% |
| Onconetix, Inc. | -36.7 Million USD | 2040.813% |
| Oncternal Therapeutics, Inc. | 2.23 Million USD | -31775.123% |
| Opthea Limited | -200.01 Million USD | 456.171% |
| Psyence Biomedical Ltd. | -2.75 Million USD | 25990.906% |
| Vaxcyte, Inc. | -464.88 Million USD | 253.244% |
| PDS Biotechnology Corporation | -40.08 Million USD | 1877.247% |
| Precigen, Inc. | -89.22 Million USD | 898.432% |
| Pharming Group N.V. | 9.87 Million USD | -7112.808% |
| Phathom Pharmaceuticals, Inc. | -159.04 Million USD | 547.918% |
| Pieris Pharmaceuticals, Inc. | -22.76 Million USD | 3229.817% |
| PureTech Health plc | -11.62 Million USD | 6227.195% |
| Rigel Pharmaceuticals, Inc. | -16.98 Million USD | 4295.33% |
| Avidity Biosciences, Inc. | -233.49 Million USD | 405.104% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | 3054.595% |
| Sangamo Therapeutics, Inc. | -87.42 Million USD | 914.862% |
| Sol-Gel Technologies Ltd. | -28.96 Million USD | 2559.721% |
| Acelyrin, Inc. | -381.52 Million USD | 286.726% |
| Salarius Pharmaceuticals, Inc. | -12.88 Thousand USD | 5529126.635% |
| Summit Therapeutics Inc. | 1 Million USD | -71069.73% |
| Sensei Biotherapeutics, Inc. | -33.38 Million USD | 2233.856% |
| Senti Biosciences, Inc. | -61.33 Million USD | 1261.486% |
| Stoke Therapeutics, Inc. | -112.3 Million USD | 734.358% |
| Elevation Oncology, Inc. | -41.46 Million USD | 1818.014% |
| Alaunos Therapeutics, Inc. | -30.9 Million USD | 2405.232% |
| Telomir Pharmaceuticals, Inc. Common Stock | -6.11 Million USD | 11747.243% |
| Entrada Therapeutics, Inc. | -321 Thousand USD | 222034.268% |
| VistaGen Therapeutics, Inc. | -32.45 Million USD | 2295.202% |
| Kintara Therapeutics, Inc. | -8.39 Million USD | 8585.1% |
| Wave Life Sciences Ltd. | -58.79 Million USD | 1311.786% |
| Seer, Inc. | -97.88 Million USD | 827.802% |
| Verrica Pharmaceuticals Inc. | -62.19 Million USD | 1245.407% |
| Aadi Bioscience, Inc. | -65.36 Million USD | 1189.894% |
| ESSA Pharma Inc. | -26.45 Million USD | 2792.877% |
| GlycoMimetics, Inc. | -39.12 Million USD | 1920.994% |
| GT Biopharma, Inc. | 5.97 Million USD | -11815.186% |
| Inhibrx Biosciences, Inc. | -206.69 Million USD | 444.67% |
| Akebia Therapeutics, Inc. | -6.86 Million USD | 10472.874% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | -720.634% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | 1355.258% |
| Orchestra BioMed Holdings, Inc. | -51.21 Million USD | 1490.908% |
| Alzamend Neuro, Inc. | -9.88 Million USD | 7305.582% |
| Sorrento Therapeutics, Inc. | -539.92 Million USD | 231.945% |
| TRACON Pharmaceuticals, Inc. | -6.88 Million USD | 10448.765% |
| Viracta Therapeutics, Inc. | -46.86 Million USD | 1620.227% |
| Rocket Pharmaceuticals, Inc. | -236.62 Million USD | 401.075% |
| Aptose Biosciences Inc. | -52.26 Million USD | 1462.993% |
| ZyVersa Therapeutics, Inc. | -107.74 Million USD | 761.209% |
| Soligenix, Inc. | -7.85 Million USD | 9171.98% |
| Century Therapeutics, Inc. | -121.2 Million USD | 687.757% |
| Kura Oncology, Inc. | -164.95 Million USD | 531.881% |
| TScan Therapeutics, Inc. | -80.09 Million USD | 989.422% |
| Intensity Therapeutics, Inc. | -10.08 Million USD | 7163.345% |
| Ocean Biomedical, Inc. | -957.73 Thousand USD | 74484.462% |
| CytomX Therapeutics, Inc. | -4.3 Million USD | 16633.047% |
| Autolus Therapeutics plc | -156.77 Million USD | 554.429% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | 941.524% |
| EyePoint Pharmaceuticals, Inc. | -69 Million USD | 1132.462% |
| Eterna Therapeutics Inc. | -19.93 Million USD | 3673.839% |
| Adaptive Biotechnologies Corporation | -189.27 Million USD | 476.392% |
| GRI Bio, Inc. | -10.89 Million USD | 6637.062% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | 15876.217% |
| Tenaya Therapeutics, Inc. | -122.5 Million USD | 681.53% |
| IGM Biosciences, Inc. | -253.35 Million USD | 381.187% |
| INmune Bio, Inc. | - USD | -Infinity% |
| Heron Therapeutics, Inc. | -103.79 Million USD | 786.381% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | 1968.211% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | 4746.881% |
| Entero Therapeutics, Inc. | -15.74 Million USD | 4625.173% |
| Milestone Pharmaceuticals Inc. | -56.84 Million USD | 1353.248% |
| X4 Pharmaceuticals, Inc. | -107.1 Million USD | 765.163% |
| Atara Biotherapeutics, Inc. | -265.99 Million USD | 367.826% |
| Coherus BioSciences, Inc. | -193.93 Million USD | 467.337% |
| Verastem, Inc. | -83.16 Million USD | 956.611% |
| Abeona Therapeutics Inc. | -50.57 Million USD | 1508.702% |
| Pliant Therapeutics, Inc. | -158.22 Million USD | 550.242% |
| Tonix Pharmaceuticals Holding Corp. | -114.08 Million USD | 724.433% |
| Histogen Inc. | -10.5 Million USD | 6882.91% |
| Aprea Therapeutics, Inc. | -14.27 Million USD | 5088.961% |
| Surrozen, Inc. | -41.13 Million USD | 1832.049% |
| Organovo Holdings, Inc. | -14.8 Million USD | 4911.624% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | -22214087.714% |
| Ovid Therapeutics Inc. | -58.71 Million USD | 1313.371% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | 1488.874% |
| CASI Pharmaceuticals, Inc. | -21.53 Million USD | 3407.531% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.33 Million USD | 8644.118% |
| Centessa Pharmaceuticals plc | -166.06 Million USD | 528.991% |
| Hepion Pharmaceuticals, Inc. | -49.25 Million USD | 1546.267% |
| Arcturus Therapeutics Holdings Inc. | -24.16 Million USD | 3047.981% |
| BioRestorative Therapies, Inc. | -15.05 Million USD | 4832.03% |
| Apollomics, Inc. | -171.74 Million USD | 514.801% |
| Amarin Corporation plc | -50.9 Million USD | 1499.583% |
| Mesoblast Limited | -61.33 Million USD | 1261.581% |
| Turnstone Biologics Corp. | -56.23 Million USD | 1366.865% |
| Kymera Therapeutics, Inc. | -143.2 Million USD | 597.489% |
| Synaptogenix, Inc. | -8.3 Million USD | 8675.485% |
| Tiziana Life Sciences Ltd | -15.33 Million USD | 4744.429% |
| Aurinia Pharmaceuticals Inc. | -63.04 Million USD | 1229.965% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | 14968.289% |
| Monopar Therapeutics Inc. | 429.03 Thousand USD | -165947.609% |
| Exelixis, Inc. | 196.6 Million USD | -262.361% |
| Better Therapeutics, Inc. | -38.26 Million USD | 1961.923% |
| Nurix Therapeutics, Inc. | -141.4 Million USD | 603.793% |
| Apellis Pharmaceuticals, Inc. | -495.21 Million USD | 243.86% |
| NLS Pharmaceutics AG | -11.79 Million USD | 6139.588% |
| Dermata Therapeutics, Inc. | 247.21 Thousand USD | -288072.691% |
| Aridis Pharmaceuticals, Inc. | -29.5 Million USD | 2514.455% |
| Gritstone bio, Inc. | -126.86 Million USD | 661.558% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | 1196.267% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | 17910.465% |
| Avid Bioservices, Inc. | -11.48 Million USD | 6305.113% |
| Insmed Incorporated | -654.73 Million USD | 208.808% |
| Virpax Pharmaceuticals, Inc. | -2.24 Million USD | 31766.577% |
| MediWound Ltd. | -4.89 Million USD | 14659.759% |
| OmniAb, Inc. | -49.73 Million USD | 1532.525% |
| Alector, Inc. | -142.89 Million USD | 598.565% |
| Seres Therapeutics, Inc. | -85.43 Million USD | 933.871% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | 1466.129% |
| Zai Lab Limited | -366.57 Million USD | 294.343% |
| Revance Therapeutics, Inc. | -290.63 Million USD | 345.12% |
| Aura Biosciences, Inc. | -83.69 Million USD | 951.186% |
| Lyell Immunopharma, Inc. | -225.24 Million USD | 416.276% |
| Immunic, Inc. | -99.11 Million USD | 818.792% |
| Tarsus Pharmaceuticals, Inc. | -131.67 Million USD | 641.056% |
| Veracyte, Inc. | -49.4 Million USD | 1541.861% |
| InMed Pharmaceuticals Inc. | -7.06 Million USD | 10185.164% |
| FibroGen, Inc. | -261.4 Million USD | 372.531% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | 6494.48% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | 10275.341% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.71 Million USD | 3906.241% |
| Jazz Pharmaceuticals plc | 1.44 Billion USD | 50.849% |
| Cyclacel Pharmaceuticals, Inc. | -25.42 Million USD | 2902.333% |
| Amylyx Pharmaceuticals, Inc. | 39.89 Million USD | -1685.934% |
| TG Therapeutics, Inc. | 26.1 Million USD | -2629.536% |
| Galecto, Inc. | -37.51 Million USD | 1998.795% |
| Calithera Biosciences, Inc. | -38.26 Million USD | 1961.777% |
| Fortrea Holdings Inc. | 167.3 Million USD | -325.827% |
| KalVista Pharmaceuticals, Inc. | -134.28 Million USD | 630.54% |
| Aptevo Therapeutics Inc. | -28.31 Million USD | 2616.368% |
| XBiotech Inc. | -35.76 Million USD | 2091.861% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | 1196.267% |
| Lyra Therapeutics, Inc. | -65.25 Million USD | 1191.815% |
| Foghorn Therapeutics Inc. | -104.45 Million USD | 782.025% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | 2875.043% |
| Theravance Biopharma, Inc. | -40.86 Million USD | 1843.238% |
| Ultragenyx Pharmaceutical Inc. | -516.45 Million USD | 237.942% |
| Metagenomi, Inc. Common Stock | -56.02 Million USD | 1371.682% |
| Vaxxinity, Inc. | -56.05 Thousand USD | 1271101.409% |
| BioCryst Pharmaceuticals, Inc. | -116.33 Million USD | 712.377% |
| Gain Therapeutics, Inc. | -22.16 Million USD | 3313.457% |
| Cartesian Therapeutics, Inc. | -235.06 Million USD | 403.07% |
| NexImmune, Inc. | -28.16 Million USD | 2629.187% |
| Creative Medical Technology Holdings, Inc. | -5.52 Million USD | 12993.002% |
| Marker Therapeutics, Inc. | -11.79 Million USD | 6141.321% |
| Regeneron Pharmaceuticals, Inc. | 4.65 Billion USD | 84.693% |
| Chemomab Therapeutics Ltd. | -25.39 Million USD | 2905.644% |
| Scopus BioPharma Inc. | -11.71 Million USD | 6182.13% |
| RAPT Therapeutics, Inc. | -125.84 Million USD | 666.096% |
| Ainos, Inc. | -8.77 Million USD | 8220.381% |
| Pluri Inc. | -20.22 Million USD | 3622.418% |
| Prothena Corporation plc | -190.1 Million USD | 474.739% |
| Adaptimmune Therapeutics plc | -128.19 Million USD | 655.71% |
| Celularity Inc. | -183.94 Million USD | 487.292% |
| Rallybio Corporation | -72.37 Million USD | 1084.357% |
| Cue Biopharma, Inc. | -46.05 Million USD | 1646.966% |
| MeiraGTx Holdings plc | -57.05 Million USD | 1348.701% |
| Omeros Corporation | -163.61 Million USD | 535.431% |
| Humacyte, Inc. | -96.45 Million USD | 838.569% |
| Immunocore Holdings plc | -59.64 Million USD | 1294.335% |
| Cocrystal Pharma, Inc. | -19.37 Million USD | 3777.519% |
| Cidara Therapeutics, Inc. | -24.36 Million USD | 3023.903% |
| Blueprint Medicines Corporation | -474.61 Million USD | 250.103% |
| CalciMedica, Inc. | -34.18 Million USD | 2183.737% |
| Cabaletta Bio, Inc. | -73.23 Million USD | 1072.784% |
| Marinus Pharmaceuticals, Inc. | -125.49 Million USD | 667.67% |
| Scholar Rock Holding Corporation | -168.45 Million USD | 522.918% |
| Sana Biotechnology, Inc. | -252.39 Million USD | 382.265% |
| Pulmatrix, Inc. | -12.64 Million USD | 5733.473% |
| Elicio Therapeutics, Inc. | -32.96 Million USD | 2261.042% |
| Vigil Neuroscience, Inc. | -88.46 Million USD | 905.282% |
| Intellia Therapeutics, Inc. | -506.31 Million USD | 240.705% |
| Adlai Nortye Ltd. American Depositary Shares | -101.21 Million USD | 803.857% |
| Cytokinetics, Incorporated | -456.68 Million USD | 255.996% |
| Eloxx Pharmaceuticals, Inc. | -33.37 Million USD | 2234.687% |
| Nutriband Inc. | -5.12 Million USD | 14009.411% |
| Protara Therapeutics, Inc. | -43.27 Million USD | 1746.351% |
| Vor Biopharma Inc. | -114.37 Million USD | 722.893% |
| Roivant Sciences Ltd. | -996.51 Million USD | 171.49% |
| Evogene Ltd. | -23.2 Million USD | 3170.199% |
| ProKidney Corp. | -147.66 Million USD | 582.436% |
| Applied Therapeutics, Inc. | -64.53 Million USD | 1203.911% |
| Hoth Therapeutics, Inc. | -153.14 Thousand USD | 465273.785% |
| BridgeBio Pharma, Inc. | -565.46 Million USD | 225.986% |
| CorMedix Inc. | -48.88 Million USD | 1557.256% |
| BioLineRx Ltd. | -57.06 Million USD | 1348.504% |
| Tango Therapeutics, Inc. | -111.75 Million USD | 737.457% |
| Galectin Therapeutics Inc. | -202 Thousand USD | 352777.723% |
| Atai Life Sciences N.V. | -36.31 Million USD | 2061.965% |
| Renovaro Biosciences Inc. | -79.51 Million USD | 995.92% |
| Aerovate Therapeutics, Inc. | -81.31 Million USD | 976.132% |
| Zentalis Pharmaceuticals, Inc. | -275.5 Million USD | 358.585% |
| Sagimet Biosciences Inc. | -30.74 Million USD | 2417.531% |
| MediciNova, Inc. | -9.87 Million USD | 7310.639% |
| Praxis Precision Medicines, Inc. | -125.94 Million USD | 665.669% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | 46656.563% |
| GeoVax Labs, Inc. | -26.66 Million USD | 2771.323% |
| Axsome Therapeutics, Inc. | -224.99 Million USD | 416.639% |
| Biomea Fusion, Inc. | -124.62 Million USD | 671.665% |
| PTC Therapeutics, Inc. | -330.34 Million USD | 315.659% |
| Mereo BioPharma Group plc | -26.05 Million USD | 2834.146% |
| Cullinan Oncology, Inc. | -190.33 Million USD | 474.284% |
| Syndax Pharmaceuticals, Inc. | -229.94 Million USD | 409.821% |
| Absci Corporation | -95.45 Million USD | 846.314% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | 2472.719% |
| 4D Molecular Therapeutics, Inc. | -107.11 Million USD | 765.069% |
| Dyne Therapeutics, Inc. | -233.47 Million USD | 405.132% |
| Kiniksa Pharmaceuticals, Ltd. | -22.85 Million USD | 3217.082% |
| Ventyx Biosciences, Inc. | -207.83 Million USD | 442.775% |
| Allakos Inc. | -189.91 Million USD | 475.12% |
| Imunon, Inc. | -19.87 Million USD | 3683.857% |
| Fulcrum Therapeutics, Inc. | -108.49 Million USD | 756.647% |
| Corcept Therapeutics Incorporated | 108.32 Million USD | -557.665% |
| BioAtla, Inc. | -122.24 Million USD | 682.791% |
| NLS Pharmaceutics AG | -11.79 Million USD | 6139.588% |
| Bio-Path Holdings, Inc. | -15.76 Million USD | 4620.075% |
| Allogene Therapeutics, Inc. | -300.29 Million USD | 337.238% |
| Larimar Therapeutics, Inc. | -41.44 Million USD | 1818.843% |
| XOMA Corporation | -39.36 Million USD | 1909.89% |
| Kezar Life Sciences, Inc. | -99.25 Million USD | 817.764% |
| Cara Therapeutics, Inc. | -117.65 Million USD | 705.533% |
| aTyr Pharma, Inc. | -52.17 Million USD | 1465.344% |
| Aligos Therapeutics, Inc. | -83.81 Million USD | 949.978% |
| Akero Therapeutics, Inc. | -148.63 Million USD | 579.314% |
| Viridian Therapeutics, Inc. | -234.56 Million USD | 403.715% |
| Eliem Therapeutics, Inc. | -13.65 Million USD | 5317.967% |
| EyeGate Pharmaceuticals, Inc. | -8.04 Million USD | 8958.274% |
| Akari Therapeutics, Plc | -16.8 Million USD | 4340.025% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | -377423.237% |
| Halozyme Therapeutics, Inc. | 451.94 Million USD | -57.631% |
| Lexaria Bioscience Corp. | -6.38 Million USD | 11251.21% |
| UroGen Pharma Ltd. | -63.83 Million USD | 1216.086% |
| Sutro Biopharma, Inc. | -67.91 Million USD | 1148.972% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | 9908.727% |
| Orgenesis Inc. | -60.71 Million USD | 1273.308% |
| Entera Bio Ltd. | -8.8 Million USD | 8191.879% |
| GH Research PLC | -41.15 Million USD | 1831.123% |
| Lisata Therapeutics, Inc. | -25.51 Million USD | 2891.681% |
| Reneo Pharmaceuticals, Inc. | -82.23 Million USD | 966.33% |
| Xencor, Inc. | -125.87 Million USD | 665.97% |
| 60 Degrees Pharmaceuticals, Inc. | -1.42 Million USD | 50039.469% |
| Replimune Group, Inc. | -230.19 Million USD | 409.477% |
| Coeptis Therapeutics Holdings, Inc. | -20.15 Million USD | 3634.192% |
| Vanda Pharmaceuticals Inc. | -10.94 Million USD | 6610.775% |
| Lexaria Bioscience Corp. | -6.38 Million USD | 11251.21% |
| Portage Biotech Inc. | -18.19 Million USD | 4014.55% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | 46656.563% |
| Olema Pharmaceuticals, Inc. | -104.58 Million USD | 781.184% |
| OncoCyte Corporation | -23.12 Million USD | 3180.954% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | 6404.302% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | 6318.199% |
| Purple Biotech Ltd. | -22.22 Million USD | 3305.44% |
| CollPlant Biotechnologies Ltd. | -6.41 Million USD | 11214.025% |
| scPharmaceuticals Inc. | -46.06 Million USD | 1646.664% |
| ProMIS Neurosciences, Inc. | -17.8 Million USD | 4100.122% |
| HilleVax, Inc. | -132.46 Million USD | 637.805% |
| NeuroSense Therapeutics Ltd. | -10.63 Million USD | 6799.981% |
| Tharimmune, Inc. | -9.3 Million USD | 7758.18% |
| Genprex, Inc. | -31.06 Million USD | 2393.612% |
| Neumora Therapeutics, Inc. Common Stock | -187.52 Million USD | 479.899% |
| Atossa Therapeutics, Inc. | -31.35 Million USD | 2372.147% |
| XTL Biopharmaceuticals Ltd. | -764 Thousand USD | 93347.251% |
| Virios Therapeutics, Inc. | 150.9 Thousand USD | -471994.179% |
| OKYO Pharma Limited | -15.74 Thousand USD | 4524518.149% |
| Savara Inc. | -59.13 Million USD | 1304.757% |
| Curis, Inc. | -45.13 Million USD | 1678.256% |
| Daré Bioscience, Inc. | -30.7 Million USD | 2420.436% |
| Carmell Therapeutics Corporation | -15.19 Million USD | 4789.632% |
| Titan Pharmaceuticals, Inc. | -7.16 Million USD | 10042.903% |
| Achieve Life Sciences, Inc. | -26.73 Million USD | 2764.805% |
| BeiGene, Ltd. | -1.12 Billion USD | 163.347% |
| Kiromic BioPharma, Inc. | -16.3 Million USD | 4470.286% |
| Revolution Medicines, Inc. Warrant | -430.58 Million USD | 265.453% |
| Protagonist Therapeutics, Inc. | -90.34 Million USD | 888.586% |
| Erasca, Inc. | -121.31 Million USD | 687.263% |
| bluebird bio, Inc. | -167.16 Million USD | 526.181% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | 15935.689% |
| BioMarin Pharmaceutical Inc. | 310.28 Million USD | -129.599% |
| DBV Technologies S.A. | -85.98 Million USD | 928.556% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | 15935.689% |
| Moderna, Inc. | -3.28 Billion USD | 121.7% |
| Vincerx Pharma, Inc. | -42.6 Million USD | 1771.968% |
| Fresh Tracks Therapeutics, Inc. | -5.64 Million USD | 12713.474% |
| Molecular Templates, Inc. | 1.43 Million USD | -49718.811% |
| Acrivon Therapeutics, Inc. Common Stock | -59.85 Million USD | 1290.284% |
| Travere Therapeutics, Inc. | -326.24 Million USD | 318.366% |
| Monte Rosa Therapeutics, Inc. | -137.08 Million USD | 619.669% |
| Spruce Biosciences, Inc. | -47.36 Million USD | 1604.051% |
| Celldex Therapeutics, Inc. | -139.03 Million USD | 612.399% |
| Cogent Biosciences, Inc. | -205.86 Million USD | 446.065% |
| MacroGenics, Inc. | 2.01 Million USD | -35220.228% |
| RenovoRx, Inc. | -11.39 Million USD | 6354.688% |
| Adicet Bio, Inc. | -136.53 Million USD | 621.778% |
| Prime Medicine, Inc. | -193.75 Million USD | 467.678% |
| Aditxt, Inc. | -25.45 Million USD | 2898.374% |
| Adagene Inc. | -14.95 Million USD | 4865.027% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | 9845.547% |
| Quantum-Si incorporated | -91.8 Million USD | 876.011% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 126.45 Million USD | -463.37% |
| SciSparc Ltd. | -5.28 Million USD | 13587.486% |
| Vericel Corporation | 2.86 Million USD | -24774.616% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | 748365.902% |
| Minerva Neurosciences, Inc. | -21.69 Million USD | 3384.288% |
| Generation Bio Co. | -133.3 Million USD | 634.44% |
| Astria Therapeutics, Inc. | -83.03 Million USD | 958.014% |
| Black Diamond Therapeutics, Inc. | -86.02 Million USD | 928.161% |
| Arcutis Biotherapeutics, Inc. | -227.43 Million USD | 413.238% |
| Invivyd, Inc. | -196.61 Million USD | 462.337% |
| Relay Therapeutics, Inc. | -374.15 Million USD | 290.406% |
| Quoin Pharmaceuticals, Ltd. | -9.27 Million USD | 7781.127% |
| Spero Therapeutics, Inc. | 27.15 Million USD | -2523.588% |
| Artelo Biosciences, Inc. | -10.28 Million USD | 7026.68% |
| 2seventy bio, Inc. | -206.41 Million USD | 445.129% |
| ADMA Biologics, Inc. | 5.12 Million USD | -13814.238% |
| Clene Inc. | -43.24 Million USD | 1747.531% |
| Capricor Therapeutics, Inc. | -23 Million USD | 3196.222% |
| Boundless Bio, Inc. Common Stock | -48.47 Million USD | 1569.581% |
| GeoVax Labs, Inc. | -26.66 Million USD | 2771.323% |
| Recursion Pharmaceuticals, Inc. | -299.56 Million USD | 337.814% |
| Citius Pharmaceuticals, Inc. | -36.72 Million USD | 2039.618% |
| Contineum Therapeutics, Inc. Class A Common Stock | 23.57 Million USD | -2922.14% |
| Relmada Therapeutics, Inc. | 4.91 Million USD | -14408.595% |
| Finch Therapeutics Group, Inc. | -32.48 Million USD | 2293.242% |
| ALX Oncology Holdings Inc. | -158.4 Million USD | 549.742% |
| Vir Biotechnology, Inc. | -684.3 Million USD | 204.107% |
| Evaxion Biotech A/S | -21.4 Million USD | 3428.547% |
| Ocular Therapeutix, Inc. | -66.41 Million USD | 1172.663% |
| Verve Therapeutics, Inc. | -217.66 Million USD | 427.29% |
| Trevena, Inc. | -35.28 Million USD | 2118.842% |
| Surrozen, Inc. | -41.13 Million USD | 1832.049% |
| Tyra Biosciences, Inc. | -79.59 Million USD | 995.076% |
| Cingulate Inc. | -22.95 Million USD | 3203.904% |
| Galmed Pharmaceuticals Ltd. | -7.46 Million USD | 9648.439% |
| Unity Biotechnology, Inc. | -37.28 Million USD | 2010.815% |
| Tenax Therapeutics, Inc. | -8.22 Million USD | 8760.064% |
| Terns Pharmaceuticals, Inc. | -102.26 Million USD | 796.624% |
| ACADIA Pharmaceuticals Inc. | -67.82 Million USD | 1150.332% |
| Connect Biopharma Holdings Limited | -58.37 Million USD | 1320.464% |
| Clearmind Medicine Inc. | -8.71 Million USD | 8278.586% |
| Kronos Bio, Inc. | -121.83 Million USD | 684.757% |
| Bolt Biotherapeutics, Inc. | -74.34 Million USD | 1058.286% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | 29280.18% |
| Viking Therapeutics, Inc. | -100.82 Million USD | 806.566% |
| Statera Biopharma, Inc. | 38.93 Million USD | -1729.742% |
| ImmunityBio, Inc. | -436.18 Million USD | 263.328% |
| Korro Bio, Inc. | -80.9 Million USD | 980.561% |
| Kineta, Inc. | -15.71 Million USD | 4633.594% |
| BioVie Inc. | -31.95 Million USD | 2329.748% |
| Codexis, Inc. | -49.28 Million USD | 1545.547% |
| Celularity Inc. | -183.94 Million USD | 487.292% |
| Crinetics Pharmaceuticals, Inc. | -221.51 Million USD | 421.615% |
| Celcuity Inc. | -58.3 Million USD | 1321.762% |
| Virax Biolabs Group Limited | -6.6 Million USD | 10879.142% |
| Cibus, Inc. | -314.58 Million USD | 326.46% |
| Eledon Pharmaceuticals, Inc. | - USD | -Infinity% |
| eFFECTOR Therapeutics, Inc. | -33.73 Million USD | 2211.905% |
| IN8bio, Inc. | -28.5 Million USD | 2599.33% |
| Kodiak Sciences Inc. | -259.02 Million USD | 375.037% |
| Annexon, Inc. | -141.57 Million USD | 603.203% |
| Adverum Biotechnologies, Inc. | -112.59 Million USD | 732.696% |
| Assembly Biosciences, Inc. | -64.19 Million USD | 1209.74% |
| Avalo Therapeutics, Inc. | -27.95 Million USD | 2648.414% |
| Ionis Pharmaceuticals, Inc. | -230.01 Million USD | 409.73% |
| Eyenovia, Inc. | -24.1 Million USD | 3055.314% |
| Puma Biotechnology, Inc. | 44.78 Million USD | -1490.767% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | 219979.321% |
| Xilio Therapeutics, Inc. | -73.8 Million USD | 1065.272% |
| Arcellx, Inc. | -64.14 Million USD | 1210.623% |
| Cardiff Oncology, Inc. | -45.01 Million USD | 1682.639% |
| Enanta Pharmaceuticals, Inc. | -123.47 Million USD | 676.962% |
| Regulus Therapeutics Inc. | -30.88 Million USD | 2406.875% |
| Moolec Science SA | -52.07 Million USD | 1468.03% |
| Acumen Pharmaceuticals, Inc. | -51.6 Million USD | 1480.477% |
| Geron Corporation | -174.78 Million USD | 507.599% |
| LAVA Therapeutics N.V. | -40.41 Million USD | 1862.647% |
| Royalty Pharma plc | 1.88 Billion USD | 62.252% |
| Atea Pharmaceuticals, Inc. | -119.59 Million USD | 695.695% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | 7740.386% |
| TFF Pharmaceuticals, Inc. | -20.74 Million USD | 3534.827% |
| Mersana Therapeutics, Inc. | -166.08 Million USD | 528.955% |
| Humacyte, Inc. | -96.45 Million USD | 838.569% |
| Structure Therapeutics Inc. | -102.45 Million USD | 795.311% |
| 89bio, Inc. | -134.46 Million USD | 629.818% |
| PMV Pharmaceuticals, Inc. | -78.87 Million USD | 1003.213% |
| Avenue Therapeutics, Inc. | 4.05 Million USD | -17481.663% |
| Genelux Corporation | -24.16 Million USD | 3048.103% |
| Trevi Therapeutics, Inc. | -33.8 Million USD | 2207.719% |
| Lexicon Pharmaceuticals, Inc. | -163.46 Million USD | 535.82% |
| Notable Labs, Ltd. | -14.4 Million USD | 5047.285% |
| Liquidia Corporation | -70.05 Million USD | 1116.986% |
| Mustang Bio, Inc. | -48.06 Million USD | 1582.24% |
| Immunovant, Inc. | -269.97 Million USD | 363.877% |
| Quantum-Si incorporated | -91.8 Million USD | 876.011% |
| Arbutus Biopharma Corporation | -70.98 Million USD | 1103.591% |
| DiaMedica Therapeutics Inc. | -19.3 Million USD | 3789.709% |
| Vera Therapeutics, Inc. | -102.01 Million USD | 798.358% |
| Acasti Pharma Inc. | -11.3 Million USD | 6403.947% |
| MiNK Therapeutics, Inc. | -22.25 Million USD | 3301.372% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | 4746.881% |
| Xenon Pharmaceuticals Inc. | -210.51 Million USD | 438.416% |
| Elevai Labs, Inc. Common Stock | -4.27 Million USD | 16782.711% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | 4586.203% |
| Tempest Therapeutics, Inc. | -28.77 Million USD | 2575.705% |
| Soleno Therapeutics, Inc. | -37.03 Million USD | 2023.87% |
| PepGen Inc. | -83.58 Million USD | 952.347% |
| Moleculin Biotech, Inc. | -29.5 Million USD | 2514.618% |
| United Therapeutics Corporation | 1.38 Billion USD | 48.629% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 3211.364% |
| Solid Biosciences Inc. | -93.43 Million USD | 862.473% |
| BriaCell Therapeutics Corp. | -4.77 Million USD | 15029.766% |
| Immuneering Corporation | -58.06 Million USD | 1327.005% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | -22214087.714% |
| Silo Pharma, Inc. | -3.62 Million USD | 19746.083% |
| Belite Bio, Inc | -31.52 Million USD | 2359.536% |
| XOMA Corporation | -39.36 Million USD | 1909.89% |
| ARS Pharmaceuticals, Inc. | -67.44 Million USD | 1156.25% |
| Bionomics Limited | -9.83 Million USD | 7342.141% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | 948.257% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | 2158.629% |
| uniQure N.V. | -253.1 Million USD | 381.473% |
| Cassava Sciences, Inc. | -95.68 Million USD | 844.52% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | 9845.547% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | 650.106% |
| Forte Biosciences, Inc. | -32.47 Million USD | 2293.58% |
| Anebulo Pharmaceuticals, Inc. | -8.05 Million USD | 8949.281% |
| Enlivex Therapeutics Ltd. | -28.21 Million USD | 2624.572% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | 219979.321% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | 6494.48% |
| FibroBiologics, Inc. Common Stock | -15.9 Million USD | 4580.278% |
| Altimmune, Inc. | -87.93 Million USD | 910.154% |
| Amicus Therapeutics, Inc. | -92.07 Million USD | 873.693% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | 2158.629% |
| Compugen Ltd. | -12.51 Million USD | 5791.986% |
| Peak Bio, Inc. | -1356.23 USD | 52528727.15% |
| Zevra Therapeutics, Inc. | -48.59 Million USD | 1565.922% |
| Benitec Biopharma Inc. | -22.49 Million USD | 3267.67% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | 394.016% |
| NKGen Biotech, Inc. Common Stock | -28.54 Million USD | 2595.915% |
| Zura Bio Limited | -60.56 Million USD | 1276.311% |
| PolyPid Ltd. | -20.26 Million USD | 3615.812% |
| Aileron Therapeutics, Inc. | -15.61 Million USD | 4662.922% |
| NKGen Biotech, Inc. Warrants | -28.54 Million USD | 2595.915% |
| Instil Bio, Inc. | -146.12 Million USD | 587.544% |
| argenx SE | -216.02 Million USD | 429.784% |
| Immunome, Inc. | -28.27 Million USD | 2619.929% |
| Compass Therapeutics, Inc. | -48.47 Million USD | 1569.703% |
| Verona Pharma plc | -52.46 Million USD | 1457.808% |
| enGene Holdings Inc. Warrants | -94.77 Million USD | 851.708% |
| Shattuck Labs, Inc. | -87.61 Million USD | 913.113% |
| CervoMed Inc. | -2.17 Million USD | 32901.581% |
| LENZ Therapeutics, Inc. | -122.24 Million USD | 682.776% |
| Plus Therapeutics, Inc. | -12.69 Million USD | 5712.613% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | 1578.825% |
| Moolec Science SA | -52.07 Million USD | 1468.03% |
| Enveric Biosciences, Inc. | -17.13 Million USD | 4256.416% |
| Inovio Pharmaceuticals, Inc. | -130.39 Million USD | 646.364% |
| AnaptysBio, Inc. | -143.16 Million USD | 597.617% |
| Design Therapeutics, Inc. | -66.32 Million USD | 1174.118% |
| Leap Therapeutics, Inc. | -80.98 Million USD | 979.658% |
| NeurAxis, Inc. | -6.66 Million USD | 10789.617% |
| Seelos Therapeutics, Inc. | -37.75 Million USD | 1987.176% |
| Lumos Pharma, Inc. | -36.57 Million USD | 2048.069% |
| Achilles Therapeutics plc | -70.44 Million USD | 1111.341% |
| enGene Holdings Inc. Common Stock | -94.77 Million USD | 851.708% |
| 180 Life Sciences Corp. | -22.13 Million USD | 3318.614% |
| Opiant Pharmaceuticals, Inc. | 5.82 Million USD | -12121.287% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | 29280.18% |
| Nutriband Inc. | -5.12 Million USD | 14009.411% |
| ORIC Pharmaceuticals, Inc. | -109.74 Million USD | 749.132% |
| CG Oncology, Inc. Common stock | -55.43 Million USD | 1385.194% |
| Fractyl Health, Inc. Common Stock | -50.55 Million USD | 1509.316% |
| Rani Therapeutics Holdings, Inc. | -65.27 Million USD | 1191.363% |
| MoonLake Immunotherapeutics | -54.1 Million USD | 1416.595% |
| Palisade Bio, Inc. | -12.28 Million USD | 5900.904% |
| Tourmaline Bio, Inc. | -45.37 Million USD | 1670.013% |
| Beam Therapeutics Inc. | -156.47 Million USD | 555.292% |
| Neurogene Inc. | -52.28 Million USD | 1462.523% |
| Mirum Pharmaceuticals, Inc. | -136.49 Million USD | 621.95% |
| AEON Biopharma, Inc. | -48.36 Million USD | 1573.106% |
| CARGO Therapeutics, Inc. Common Stock | -93.01 Million USD | 865.883% |
| Sesen Bio, Inc. | -50.84 Million USD | 1501.277% |
| Enliven Therapeutics, Inc. | -81.93 Million USD | 969.513% |
| Kiora Pharmaceuticals, Inc. | -12.35 Million USD | 5868.483% |
| Iovance Biotherapeutics, Inc. | -427.43 Million USD | 266.672% |
| Taysha Gene Therapies, Inc. | -105.19 Million USD | 777.214% |
| Athira Pharma, Inc. | -116.7 Million USD | 710.446% |
| Vaccinex, Inc. | -19.74 Million USD | 3707.499% |
| HCW Biologics Inc. | -23.57 Million USD | 3121.748% |
| XOMA Corporation | -39.36 Million USD | 1909.89% |
| Nektar Therapeutics | -243.1 Million USD | 393.043% |
| Arvinas, Inc. | -394.8 Million USD | 280.448% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | -377423.237% |
| Merus N.V. | -149.2 Million USD | 577.464% |
| Omega Therapeutics, Inc. | -93.49 Million USD | 862.016% |
| Quince Therapeutics, Inc. | -31.26 Million USD | 2378.98% |
| Rezolute, Inc. | -68.42 Million USD | 1141.184% |
| Clene Inc. | -43.24 Million USD | 1747.531% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | 4719.376% |
| BeyondSpring Inc. | -21.54 Million USD | 3407.377% |
| Synlogic, Inc. | -55.16 Million USD | 1391.508% |
| Allarity Therapeutics, Inc. | -12.08 Million USD | 5995.961% |
| Phio Pharmaceuticals Corp. | -10.64 Million USD | 6794.315% |
| Peak Bio, Inc. | -1356.23 USD | 52528727.15% |
| Werewolf Therapeutics, Inc. | -32.46 Million USD | 2294.391% |
| Krystal Biotech, Inc. | 17.9 Million USD | -3879.049% |
| Karyopharm Therapeutics Inc. | -118.42 Million USD | 701.58% |
| SpringWorks Therapeutics, Inc. | -341.34 Million USD | 308.706% |
| Lipella Pharmaceuticals Inc. | -4.6 Million USD | 15565.527% |
| MannKind Corporation | 15.12 Million USD | -4608.897% |
| Ikena Oncology, Inc. | -74.39 Million USD | 1057.578% |
| Cyclerion Therapeutics, Inc. | -12.59 Million USD | 5757.183% |
| Gyre Therapeutics, Inc. | 20.32 Million USD | -3404.742% |
| Gossamer Bio, Inc. | -172.15 Million USD | 513.826% |
| CohBar, Inc. | -12.06 Million USD | 6004.386% |
| Cognition Therapeutics, Inc. | -25.5 Million USD | 2892.775% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | 2472.719% |
| Legend Biotech Corporation | -477.87 Million USD | 249.079% |
| Mural Oncology plc | -192.72 Million USD | 469.66% |
| Biora Therapeutics, Inc. | -114.05 Million USD | 724.624% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | 4512.494% |
| Disc Medicine, Inc. | -91.02 Million USD | 882.652% |
| Champions Oncology, Inc. | -5.05 Million USD | 14195.944% |
| REGENXBIO Inc. | -239.46 Million USD | 397.502% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | 6746.73% |
| Anavex Life Sciences Corp. | -55.75 Million USD | 1377.726% |
| Cellectar Biosciences, Inc. | -38.76 Million USD | 1937.609% |
| Edgewise Therapeutics, Inc. | -112.8 Million USD | 731.535% |
| Vaxart, Inc. | -74.72 Million USD | 1053.4% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -35.2 Million USD | 2123.412% |
| Cellectis S.A. | -98.09 Million USD | 826.244% |
| Longeveron Inc. | -20.06 Million USD | 3651.391% |
| Repare Therapeutics Inc. | -114.27 Million USD | 723.427% |
| Sarepta Therapeutics, Inc. | -439.19 Million USD | 262.208% |
| Inozyme Pharma, Inc. | -74.81 Million USD | 1052.266% |
| Revolution Medicines, Inc. | -430.58 Million USD | 265.453% |
| Nymox Pharmaceutical Corporation | -6.28 Million USD | 11427.858% |
| Third Harmonic Bio, Inc. | -30.78 Million USD | 2413.843% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | 1055.1% |
| AN2 Therapeutics, Inc. | 4.9 Million USD | -14430.063% |
| Anixa Biosciences, Inc. | -10.96 Million USD | 6597.118% |
| Vertex Pharmaceuticals Incorporated | 4.6 Billion USD | 84.53% |
| Denali Therapeutics Inc. | -179.97 Million USD | 495.842% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | 748365.902% |
| Veru Inc. | -89.97 Million USD | 891.78% |
| Corvus Pharmaceuticals, Inc. | -26.87 Million USD | 2750.528% |
| Cingulate Inc. | -22.95 Million USD | 3203.904% |
| Passage Bio, Inc. | -98.34 Million USD | 824.427% |
| Context Therapeutics Inc. | -25.06 Million USD | 2942.748% |
| Exicure, Inc. | -15.53 Million USD | 4684.652% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | 445.722% |
| Oramed Pharmaceuticals Inc. | -36.97 Million USD | 2026.679% |
| Scinai Immunotherapeutics Ltd. | -5.96 Million USD | 12047.967% |
| Rhythm Pharmaceuticals, Inc. | -168.46 Million USD | 522.885% |
| Nuvalent, Inc. | -149.49 Million USD | 576.553% |
| ABVC BioPharma, Inc. | -8.13 Million USD | 8860.116% |
| Carisma Therapeutics, Inc. | -85.89 Million USD | 929.405% |
| Unicycive Therapeutics, Inc. | -30.17 Million USD | 2460.69% |
| OmniAb, Inc. | -49.73 Million USD | 1532.525% |
| Anew Medical, Inc. | -1.3 Million USD | 54865.305% |
| Fennec Pharmaceuticals Inc. | -12.36 Million USD | 5861.962% |
| Lipocine Inc. | -16.32 Million USD | 4464.538% |
| Lexeo Therapeutics, Inc. Common Stock | -66.67 Million USD | 1168.56% |
| Nautilus Biotechnology, Inc. | -74.3 Million USD | 1058.789% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | 1968.211% |
| G1 Therapeutics, Inc. | -39.01 Million USD | 1926.034% |
| Bellerophon Therapeutics, Inc. | -22.18 Million USD | 3311.509% |
| Sage Therapeutics, Inc. | -545.07 Million USD | 230.7% |
| Ocugen, Inc. | -64.82 Million USD | 1198.939% |
| Mind Medicine (MindMed) Inc. | -92.57 Million USD | 869.589% |
| Q32 Bio Inc. | -86.5 Million USD | 923.575% |
| Brainstorm Cell Therapeutics Inc. | -16.92 Million USD | 4308.714% |
| Alumis Inc. Common Stock | -156.89 Million USD | 554.082% |
| Equillium, Inc. | -12.13 Million USD | 5969.245% |
| Kyverna Therapeutics, Inc. | -58.47 Million USD | 1318.376% |
| Coya Therapeutics, Inc. | -7.9 Million USD | 9114.014% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | 3877.159% |
| Galera Therapeutics, Inc. | -46.69 Million USD | 1625.762% |
| Evelo Biosciences, Inc. | -106.34 Million USD | 769.904% |
| Comera Life Sciences Holdings, Inc. | -17.88 Million USD | 4082.922% |
| Dominari Holdings Inc. | -22.44 Million USD | 3274.728% |
| Edesa Biotech, Inc. | -8.19 Million USD | 8798.372% |
| vTv Therapeutics Inc. | -25.41 Million USD | 2903.435% |
| Bio-Techne Corporation | 326.66 Million USD | -118.087% |
| Agios Pharmaceuticals, Inc. | -384.86 Million USD | 285.107% |
| Harmony Biosciences Holdings, Inc. | 216.38 Million USD | -229.226% |
| Prelude Therapeutics Incorporated | -131.1 Million USD | 643.376% |
| Candel Therapeutics, Inc. | -37.43 Million USD | 2003.259% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | 571.479% |
| Nkarta, Inc. | -120.48 Million USD | 691.304% |
| BioCardia, Inc. | -11.56 Million USD | 6262.708% |
| Iterum Therapeutics plc | -34.58 Million USD | 2160.176% |